$63.5 Million is the total value of Monashee Investment Management LLC's 57 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EIGR | EIGER BIOPHARMACEUTICALS INC | $1,678,000 | +18.2% | 84,680 | 0.0% | 2.64% | +1.9% | |
AVGR | AVINGER INC | $656,000 | +24.5% | 54,999 | 0.0% | 1.03% | +7.3% | |
TACO | DEL TACO RESTAURANTS INC | $154,000 | -11.5% | 16,875 | 0.0% | 0.24% | -23.6% | |
PRTO | PROTEON THERAPEUTICS INC | $117,000 | +3.5% | 14,615 | 0.0% | 0.18% | -10.7% | |
BIOAWS | BIOAMBER INC*w exp 05/09/201 | $53,000 | -80.6% | 150,000 | 0.0% | 0.08% | -83.4% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-02
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CIDARA THERAPEUTICS INC | 16 | Q3 2023 | 1.3% |
VANGUARD TOTAL STOCK MKT ETF | 12 | Q2 2023 | 82.1% |
SOMALOGIC INC | 9 | Q3 2023 | 3.4% |
BIONANO GENOMICS INC | 9 | Q4 2020 | 0.1% |
COMPASS THERAPEUTICS INC | 8 | Q3 2023 | 4.8% |
BIOMX INC | 8 | Q3 2021 | 0.0% |
AN2 THERAPEUTICS INC | 7 | Q3 2023 | 1.9% |
COLLIER CREEK HOLDINGS | 7 | Q2 2020 | 0.3% |
WHOLE EARTH BRANDS INC | 7 | Q4 2021 | 0.2% |
FINTECH ACQUISITION CORP III | 7 | Q3 2020 | 0.2% |
View Monashee Investment Management LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-02-12 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-10 |
13F-HR | 2023-05-05 |
13F-HR | 2023-02-09 |
13F-HR | 2022-11-01 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-12 |
13F-HR | 2022-02-07 |
View Monashee Investment Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.